Study: Atherosclerosis picture intervention tied to lower CVD risk | Only 1 in 8 US adults has good metabolic health, study finds | Research shows link between CAC scores, CVD events in diabetes
December 6, 2018
PCNA SmartBrief
News about cardiovascular disease prevention and management
Heart Health News
Study: Atherosclerosis picture intervention tied to lower CVD risk
Patients given carotid ultrasound pictures showing their subclinical atherosclerosis, followed by a phone call from a nurse to confirm their understanding, had lower cardiovascular risk scores at one year compared with patients who did not get the information, according to a study in The Lancet. Patients in the intervention arm of the study had greater increases in the use of lipid-lowering medication and greater decreases in LDL cholesterol.
MedPage Today (free registration) (12/4) 
LinkedIn Twitter Facebook Email
Only 1 in 8 US adults has good metabolic health, study finds
Researchers evaluated 2009-2016 data from the National Health and Nutrition Examination Survey on more than 8,700 US adults and found that just more than 12%, or only 1 in 8, had good metabolic health. The findings in Metabolic Syndrome and Related Disorders showed that female sex, younger age, higher physical activity, increased education and not smoking were linked to better metabolic health.
HealthDay News (12/4) 
LinkedIn Twitter Facebook Email
Research shows link between CAC scores, CVD events in diabetes
A study presented at the American Heart Association Scientific Sessions showed that patients with type 1 diabetes and coronary artery calcium scores of 0 were at a reduced risk for cardiovascular disease events, while those with scores over 100 had an increased risk of CVD and major adverse cardiovascular events. Findings were based on 1,205 patients from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.
Healio (free registration)/Cardiology Today (11/28) 
LinkedIn Twitter Facebook Email
Other News
Emerging Trends
Liraglutide reduces MACE, mortality risks in older diabetes patients
Patients ages 75 or older with type 2 diabetes who received liraglutide experienced a 34% and 29% reduced risk in the frequency of major adverse cardiovascular events and expanded MACE outcomes, respectively, with less prominent reductions seen among those ages 60 to 74, compared with those on placebo, according to a study in the Annals of Internal Medicine. Researchers used a cohort of 7,019 patients from the LEADER trial and found that the liraglutide group also had a reduced all-cause mortality risk.
Healio (free registration) (12/3) 
LinkedIn Twitter Facebook Email
Study compares dapagliflozin, vildagliptin on diabetes, CAD
Researchers recruited 43 patients with type 2 diabetes and coronary artery disease, mean age of 63, and found those who received dapagliflozin for six months had reduced body mass index, high-sensitive troponin T and systolic blood pressure and increased mean hemoglobin, compared with those who received vildagliptin. The findings, presented at the American Heart Association Scientific Sessions, revealed no significant differences in changes in lipid profiles and inflammatory markers between the two groups.
Healio (free registration)/Cardiology Today (11/29) 
LinkedIn Twitter Facebook Email
Nursing in the News
Surveys look at NP salaries, ageism in nursing
A Medscape poll found 64% of nurses said they believed ageism was a factor in being passed over for a job opportunity, compared with 44% of physicians. Meanwhile, a salary report on advanced practice registered nurses found an average 6% rise in pay for nurse practitioners last year.
Medscape (free registration) (12/3),  Medscape (free registration) (11/30) 
LinkedIn Twitter Facebook Email
PCNA Update
Today: Cholesterol guidelines webinar
Keep up-to-date with changes in guidelines with our one-hour live webinar today at 4 p.m. ET, 3 p.m. CT, 2 p.m. MT, 1 p.m. PT. Presented by Lynne Braun, Ph.D., CNP, CLS, FAAN, who was part of the guidelines committee, this webinar is sure to help you and your patients effectively manage their cholesterol. Register for the webinar.
LinkedIn Twitter Facebook Email
Can eating yogurt reduce cardiometabolic risk?
A recent study looked at postprandial inflammation, bacterial endotoxins and the effects dairy proteins and calcium may have on these future predictors of hyperlipidemia and hyperglycemia. The bottom line: eating 8 ounces of low-fat yogurt before a meal can improve post-meal metabolism and therefore reduce the risk of cardiovascular and metabolic diseases. Read the article.
LinkedIn Twitter Facebook Email
Learn more about PCNA:
Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
All disruption starts with introspection.
Jay Samit,
digital media innovator
LinkedIn Twitter Facebook Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Molly Ufheil
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information